Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00057759 · ClinicalTrials.gov registry record · NA
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
A NA study, sponsored by Radiation Therapy Oncology Group.
- Completed
- Registry status
- NA
- Development phase
- 115
- Enrollment target
NCT00057759 is a NA study that has completed, run by Radiation Therapy Oncology Group. The registered enrollment target is 115 participants.
The verdict
NCT00057759, a NA study, has completed, sponsored by Radiation Therapy Oncology Group.
- COMPLETED
- Registry status
- NA
- Development phase
- 115 participants
- Enrollment target
Study Summary
RATIONALE: Sildenafil may be effective in helping patients who have undergone treatment for prostate cancer to have an erection for sexual activity and may improve sexual satisfaction and quality of life. PURPOSE: Randomized clinical trial to study the effectiveness of sildenafil in treating erectile dysfunction in patients who have undergone radiation therapy and hormone therapy for prostate cancer in clinical trial RTOG-9910.
Interventions
- OTHER Placebo
- DRUG sildenafil citrate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 115 participants |
| Start Date | 2003-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00057759
The ClinicalTrials.gov registry entry for NCT00057759 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 115 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Radiation Therapy Oncology Group, which has 144 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00057759 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00057759 about?
NCT00057759 is a clinical study titled "Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer". RATIONALE: Sildenafil may be effective in helping patients who have undergone treatment for prostate cancer to have an erection for sexual activity and may improve sexual satisfaction and quality of life. PURPOSE: Randomized clinical trial to study the effectiveness of sildenafil in treating erecti...
What is the current status of trial NCT00057759?
This trial is currently completed. It is a NA study. The enrollment target is 115 participants. The study started on 2003-01.
What interventions are being tested in trial NCT00057759?
The interventions under investigation include: Placebo (OTHER), sildenafil citrate (DRUG).
Who is sponsoring clinical trial NCT00057759?
This trial is sponsored by Radiation Therapy Oncology Group, which has 144 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.